Show results for
Refine by
Human Cancer Services Available In Belgium
7 services found
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
MRTX0902 is a potent SOS1 inhibitor which can be used for the therapeutic intervention of KRAS-driven (Kirsten rat sarcoma virus driven) cancers. Rat sarcoma (RAS) is the most frequently mutated oncogene in human cancer, with KRAS being the most commonly mutated RAS isoform. Overall, KRAS accounts for 85% of RAS mutations observed in ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Nude rat xenograft models provide a more appropriate platform that conquers the limitations of traditional in vivo models and more precisely represent human cancer features especially in relation to metastasis and drug ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
The ultimate goal for an ADC development project is to deploy the resulted ADC into in vivo systems, both in model animals and eventually human patients, to cure cancer and other diseases utilizing its payload ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
The ultimate goal for an ADC development project is to deploy the resulted ADC into in vivo systems, both in model animals and eventually human patients, to cure cancer and other diseases utilizing its payload efficacy. However, prior to in vivo deployment, information regarding basic biochemical characteristics and in vitro efficacy must be acquired for a proper ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
ACD has curated a collection of dozens of pre-sourced validated and un-validated tissue blocks, available to our PAS customers, to support the development of ISH probes and assays. ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
Manufactured by:Inovotion Sas based inLa Tronche, FRANCE
Pharmaceutical chemical and biology researchers need to develop new methods and models to improve the predictivity of preclinical discovery phases and increase the number of good molecules in clinic. INOVOTION’s unique in vivo technology will allow you to raise the global number of drug candidates tested in clinic without increasing your ...